Literature DB >> 27076641

Cell-Free Hepatitis B Virus Capsid Assembly Dependent on the Core Protein C-Terminal Domain and Regulated by Phosphorylation.

Laurie Ludgate1, Kuancheng Liu1,2, Laurie Luckenbaugh1, Nicholas Streck1, Stacey Eng3, Christian Voitenleitner3, William E Delaney3, Jianming Hu4.   

Abstract

UNLABELLED: Multiple subunits of the hepatitis B virus (HBV) core protein (HBc) assemble into an icosahedral capsid that packages the viral pregenomic RNA (pgRNA). The N-terminal domain (NTD) of HBc is sufficient for capsid assembly, in the absence of pgRNA or any other viral or host factors, under conditions of high HBc and/or salt concentrations. The C-terminal domain (CTD) is deemed dispensable for capsid assembly although it is essential for pgRNA packaging. We report here that HBc expressed in a mammalian cell lysate, rabbit reticulocyte lysate (RRL), was able to assemble into capsids when (low-nanomolar) HBc concentrations mimicked those achieved under conditions of viral replication in vivo and were far below those used previously for capsid assembly in vitro Furthermore, at physiologically low HBc concentrations in RRL, the NTD was insufficient for capsid assembly and the CTD was also required. The CTD likely facilitated assembly under these conditions via RNA binding and protein-protein interactions. Moreover, the CTD underwent phosphorylation and dephosphorylation events in RRL similar to those seen in vivo which regulated capsid assembly. Importantly, the NTD alone also failed to accumulate in mammalian cells, likely resulting from its failure to assemble efficiently. Coexpression of the full-length HBc rescued NTD assembly in RRL as well as NTD expression and assembly in mammalian cells, resulting in the formation of mosaic capsids containing both full-length HBc and the NTD. These results have important implications for HBV assembly during replication and provide a facile cell-free system to study capsid assembly under physiologically relevant conditions, including its modulation by host factors. IMPORTANCE: Hepatitis B virus (HBV) is an important global human pathogen and the main cause of liver cancer worldwide. An essential component of HBV is the spherical capsid composed of multiple copies of a single protein, the core protein (HBc). We have developed a mammalian cell-free system in which HBc is expressed at physiological (low) concentrations and assembles into capsids under near-physiological conditions. In this cell-free system, as in mammalian cells, capsid assembly depends on the C-terminal domain (CTD) of HBc, in contrast to other assembly systems in which HBc assembles into capsids independently of the CTD under conditions of nonphysiological protein and salt concentrations. Furthermore, the phosphorylation state of the CTD regulates capsid assembly and RNA encapsidation in the cell-free system in a manner similar to that seen in mammalian cells. This system will facilitate detailed studies on capsid assembly and RNA encapsidation under physiological conditions and identification of antiviral agents that target HBc.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27076641      PMCID: PMC4886785          DOI: 10.1128/JVI.00394-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses.

Authors:  E V Gazina; J E Fielding; B Lin; D A Anderson
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 2.  Hepatitis B virus infection.

Authors:  Christian Trépo; Henry L Y Chan; Anna Lok
Journal:  Lancet       Date:  2014-06-18       Impact factor: 79.321

3.  Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly.

Authors:  P T Wingfield; S J Stahl; R W Williams; A C Steven
Journal:  Biochemistry       Date:  1995-04-18       Impact factor: 3.162

4.  Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase.

Authors:  J Hu; C Seeger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

5.  Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity.

Authors:  J Zachary Porterfield; Mary Savari Dhason; Daniel D Loeb; Michael Nassal; Stephen J Stray; Adam Zlotnick
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

6.  Full and empty particles of hepatitis B virus in hepatocytes from patients with HBsAg-positive chronic active hepatitis.

Authors:  Y Sakamoto; G Yamada; M Mizuno; T Nishihara; S Kinoyama; T Kobayashi; T Takahashi; H Nagashima
Journal:  Lab Invest       Date:  1983-06       Impact factor: 5.662

7.  Phosphorylation and nuclear localization of the hepatitis B virus core protein: significance of serine in the three repeated SPRRR motifs.

Authors:  W Liao; J H Ou
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  Structural organization of pregenomic RNA and the carboxy-terminal domain of the capsid protein of hepatitis B virus.

Authors:  Joseph C-Y Wang; Mary S Dhason; Adam Zlotnick
Journal:  PLoS Pathog       Date:  2012-09-20       Impact factor: 6.823

9.  A kinase chaperones hepatitis B virus capsid assembly and captures capsid dynamics in vitro.

Authors:  Chao Chen; Joseph Che-Yen Wang; Adam Zlotnick
Journal:  PLoS Pathog       Date:  2011-11-17       Impact factor: 6.823

10.  C-terminal substitution of HBV core proteins with those from DHBV reveals that arginine-rich 167RRRSQSPRR175 domain is critical for HBV replication.

Authors:  Jaesung Jung; Hee-Young Kim; Taeyeung Kim; Bo-Hye Shin; Gil-Soon Park; Sun Park; Yong-Joon Chwae; Ho-Joon Shin; Kyongmin Kim
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more
  43 in total

1.  Identification of an Intermediate in Hepatitis B Virus Covalently Closed Circular (CCC) DNA Formation and Sensitive and Selective CCC DNA Detection.

Authors:  Jun Luo; Xiuji Cui; Lu Gao; Jianming Hu
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

Review 2.  The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals.

Authors:  Ahmed Diab; Adrien Foca; Fabien Zoulim; David Durantel; Ourania Andrisani
Journal:  Antiviral Res       Date:  2017-11-26       Impact factor: 5.970

3.  Hepatitis B Virus Core Protein Dephosphorylation Occurs during Pregenomic RNA Encapsidation.

Authors:  Qiong Zhao; Zhanying Hu; Junjun Cheng; Shuo Wu; Yue Luo; Jinhong Chang; Jianming Hu; Ju-Tao Guo
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

4.  Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors.

Authors:  Xuexiang Zhang; Junjun Cheng; Julia Ma; Zhanying Hu; Shuo Wu; Nicky Hwang; John Kulp; Yanming Du; Ju-Tao Guo; Jinhong Chang
Journal:  ACS Infect Dis       Date:  2018-12-19       Impact factor: 5.084

5.  Capsid Phosphorylation State and Hepadnavirus Virion Secretion.

Authors:  Xiaojun Ning; Suresh H Basagoudanavar; Kuancheng Liu; Laurie Luckenbaugh; Duoqian Wei; Chunyan Wang; Bo Wei; Yingren Zhao; Taotao Yan; William Delaney; Jianming Hu
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

6.  Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.

Authors:  Shuo Wu; Qiong Zhao; Pinghu Zhang; John Kulp; Lydia Hu; Nicky Hwang; Jiming Zhang; Timothy M Block; Xiaodong Xu; Yanming Du; Jinhong Chang; Ju-Tao Guo
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

7.  Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.

Authors:  Lu Ruan; Jodi A Hadden; Adam Zlotnick
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

Review 8.  Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B.

Authors:  Usha Viswanathan; Nagraj Mani; Zhanying Hu; Haiqun Ban; Yanming Du; Jin Hu; Jinhong Chang; Ju-Tao Guo
Journal:  Antiviral Res       Date:  2020-08-17       Impact factor: 5.970

9.  Characterization of Hepatitis B Precore/Core-Related Antigens.

Authors:  Xupeng Hong; Laurie Luckenbaugh; Megan Mendenhall; Renae Walsh; Liza Cabuang; Sally Soppe; Peter A Revill; Dara Burdette; Becket Feierbach; William Delaney; Jianming Hu
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

10.  CpAMs induce assembly of HBV capsids with altered electrophoresis mobility: Implications for mechanism of inhibiting pgRNA packaging.

Authors:  Shuo Wu; Yue Luo; Usha Viswanathan; John Kulp; Junjun Cheng; Zhanying Hu; Qifang Xu; Yan Zhou; Guo-Zhong Gong; Jinhong Chang; Yuhuan Li; Ju-Tao Guo
Journal:  Antiviral Res       Date:  2018-09-07       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.